Type 2 Diabetes

The American Diabetes Association has adopted the 2013 ACC/AHA cholesterol guidelines in its 2015 Standards of Care -- but not entirely.

The 3 FDA-approved sodium glucose co-transporter 2 inhibitors remain under close post-marketing scrutiny. These 7 slides distill for you all the cancer risk information to date.

The Food and Drug Administration has approved a new medication to improve glycemic control in adults with type 2 diabetes.

Pre-surgical weight loss in obese patients with type 2 diabetes reduces perioperative risk. The dual benefits of GLP-1 agonists offer promise to this hard-to-treat population.

Regulation of glucose homeostasis by the kidney is impaired in persons with type 2 diabetes. Find out what you know about this renal dysfunction and the role of SGLT2 inhibition in reducing hyperglycemia.

The "inverted champagne bottle" appearance of the distal leg is a specific finding associated with this condition. Lipodermatosclerosis usually occurs in patients with long-standing venous insufficiency.

The incidence and mortality of pancreatic adenocarcinoma, the fourth leading cause of cancer deaths in the United States, are both on the rise. Globally, the disease is responsible for 227,000 deaths annually. Researchers from the National Taiwan University College of Medicine recently published a meta-analysis that demonstrated a dose-response relationship between fasting blood glucose levels and pancreatic cancer risk. They also examined the link between prediabetes and pancreatic cancer risk.

Endo Tools, Endo Pubs, Glooko--just a few of the mobile apps described here, all designed specifically for the clinical endocrinologist.

Researchers in Scotland have shown that while diabetes is a growing problem for that country's population, patients diagnosed with the condition are living considerably longer than they would have in the past. This is particularly true for patients diagnosed with type 1 diabetes.

With a new year comes New Year's resolutions, many of which involve getting healthy in the year ahead. A recent study has shown that by keeping those resolutions people can not only lose the weight they want but also avoid other health issues like diabetes.

The investigational LX4211 may one day fill a need for these patients who are unable to eliminate a lot of glucose in urine and who respond poorly to selective SGLT2 inhibitors.

Clue: What do domperidone and metoclopramide have in common?

Low total serum testosterone was independently associated with greater carotid intima media thickening and endothelial dysfunction but not with atherosclerotic plaques.

The sodium glucose cotransporter-2 inhibitors are the newest diabetes drugs available. Have you got the basic concepts under your belt? Try these 6 questions and find out.

Calculation and interpretation of the anion gap is extremely useful in the evaluation and treatment of the patient with metabolic acidosis. In this installment, we look at case examples involving patients with multiple sclerosis and urosepsis; COPD, diabetes, and renal failure; and type 1 diabetes.

A woman with poorly controlled type 2 diabetes presented with widespread “yellow bumps" of sudden onset. What's your diagnosis?

Faulty brain satiety centers and impaired gut hormone function are risk factors for weight gain in patients with type 2 diabetes. A recent study suggests one simple antidote: Slow down.

For individuals without diabetes, hemoglobin A1c (HbA1c) levels not only predicted the prevalence of coronary artery disease (CAD), but also anticipated its severity, according to research published in Mayo Clinic Proceedings.

Study results show that treatment with a proton pump inhibitor does not reduce the effectiveness of metformin treatment in patients with type 2 diabetes.

A 64-year-old obese man with type 2 diabetes presents with abrupt onset of extremely itchy rash on both upper, inner thighs. He notes mild to moderate clear oozing and a foul odor. What is this?

Some researchers now suspect that type 2 diabetes may itself be an independent risk factor for osteoarthritis and have proposed a "diabetes-induced phenotype."

The 74th Scientific Sessions of the American Diabetes Association (ADA) brought together more than 17,300 attendees from more than 121 countries. This year's program included 96 symposia, 50 oral abstract sessions, 10 interest group discussions, 18 meet-the-expert sessions, and 10 special lectures and addresses. Cardiology Review is covering 6 of the top sessions.

Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) is a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity.

Truths about necrobiosis lipoidica, advantages of SGLT2 inhibitors, rash in an obese teen, benefits of insulin therapy, knee effusions with diabetes and hypertension-these questions about diabetes put your knowledge to the test.

Drug formerly known as Zerenex gets approval following Phase 3 clinical trials